{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:25Z","timestamp":1792839745277,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12664-017-0745-5","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T02:13:31Z","timestamp":1490580811000},"page":"137-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients"],"prefix":"10.1007","volume":"36","author":[{"given":"Amit","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra Singh","family":"Bhadauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveer","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"745_CR1","first-page":"194","volume":"99","author":"D Saha","year":"2001","unstructured":"Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. J Indian Med Assoc. 2001;99:194\u20139.","journal-title":"J Indian Med Assoc"},{"key":"745_CR2","doi-asserted-by":"publisher","unstructured":"Puri P, Saraswat VA, Dhiman RK, et al. Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016. J Clin Exp Hepatol. 2016;6:119\u201345.","DOI":"10.1016\/j.jceh.2016.07.001"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","volume":"63","author":"European Association for Study of Liver","year":"2015","unstructured":"European Association for Study of Liver. EASL recommendations on treatment of hepatitis C 2015. J Hepatol. 2015;63:199\u2013236.","journal-title":"J Hepatol"},{"key":"745_CR4","unstructured":"American Association for Study of Liver Disease\/Infectious Disease Association. HCV guidance: Recommendations for testing, managing, and treating hepatitis C. \nhttp:\/\/www.hcvguidelines.org\n\n. Accessed on December 17th, 2016."},{"key":"745_CR5","unstructured":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int. 2008; 73 Suppl 109: S1\u201399."},{"key":"745_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12833","author":"A Goel","year":"2016","unstructured":"Goel A, Bhadauria DS, Kaul A, et al. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis. Nephrology (Carlton). 2016; doi:\n10.1111\/nep.12833\n\n.","journal-title":"Nephrology (Carlton)"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/ajt.12714","volume":"14","author":"EJ Gane","year":"2014","unstructured":"Gane EJ, Agarwal K. Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: \u201ca flood of opportunity\u201d. Am J Transplant. 2014;14:994\u20131002.","journal-title":"Am J Transplant"},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0971-4065.163432","volume":"26","author":"R Jha","year":"2016","unstructured":"Jha R, Fatima R, Lakhtakia S, Jha A, Srikant P, Narayan G. Ledipasvir and sofosbuvir for treatment of post-renal transplant hepatitis C infection: a case report with review of literature. Indian J Nephrol. 2016;26:216\u20139.","journal-title":"Indian J Nephrol"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"Hepatitis C guidance","year":"2015","unstructured":"Hepatitis C guidance. AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62:932\u201354.","journal-title":"Hepatology"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2015.09.002","volume":"5","author":"P Puri","year":"2015","unstructured":"Puri P, Anand AC, Saraswat VA, et al. Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection in 2015. J Clin Exp Hepatol. 2015;5:221\u201338.","journal-title":"J Clin Exp Hepatol"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/hep.27366","volume":"61","author":"EM Yoshida","year":"2015","unstructured":"Yoshida EM, Sulkowski MS, Gane EJ, et al. Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus. Hepatology. 2015;61:41\u20135.","journal-title":"Hepatology"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/tid.12524","volume":"18","author":"S Ciesek","year":"2016","unstructured":"Ciesek S, Proske V, Otto B, et al. Efficacy and safety of sofosbuvir\/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation. Transpl Infect Dis. 2016;18:326\u201332.","journal-title":"Transpl Infect Dis"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/TP.0000000000001126","volume":"100","author":"N Faisal","year":"2016","unstructured":"Faisal N, Bilodeau M, Aljudaibi B, et al. Sofosbuvir-based antiviral therapy is highly effective in recurrent hepatitis C in liver transplant recipients: Canadian multicenter \u201creal-life\u201d experience. Transplantation. 2016;100:1059\u201365.","journal-title":"Transplantation"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1016\/j.transproceed.2016.07.034","volume":"48","author":"MA Gentil","year":"2016","unstructured":"Gentil MA, Gonzalez-Corvillo C, Perello M, et al. Hepatitis C treatment with direct-acting antivirals in kidney transplant: preliminary results from a multicenter study. Transplant Proc. 2016;48:2944\u20136.","journal-title":"Transplant Proc"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/M16-1205","volume":"166","author":"M Colombo","year":"2017","unstructured":"Colombo M, Aghemo A, Liu H, et al. Treatment with ledipasvir-sofosbuvir for 12 or 24\u00a0weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial. Ann Intern Med. 2017;166:109\u201317.","journal-title":"Ann Intern Med"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ajg.2015.391","volume":"111","author":"R Wanchoo","year":"2016","unstructured":"Wanchoo R, Thakkar J, Schwartz D, Jhaveri KD. Harvoni (ledipasvir with sofosbuvir)-induced renal injury. Am J Gastroenterol. 2016;111:148\u20139.","journal-title":"Am J Gastroenterol"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1002\/phar.1803","volume":"36","author":"KL Bunnell","year":"2016","unstructured":"Bunnell KL, Vibhakar S, Glowacki RC, Gallagher MA, Osei AM, Huhn G. Nephrotoxicity associated with concomitant use of ledipasvir-sofosbuvir and tenofovir in a patient with hepatitis C virus and human immunodeficiency virus coinfection. Pharmacotherapy. 2016;36:e148\u201353.","journal-title":"Pharmacotherapy"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.meegid.2009.04.001","volume":"9","author":"S Narahari","year":"2009","unstructured":"Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of hepatitis C virus genotypes in Indian patient cohort. Infect Genet Evol. 2009;9:643\u20135.","journal-title":"Infect Genet Evol"},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/jvh.12168","volume":"20","author":"EB Tapper","year":"2013","unstructured":"Tapper EB, Afdhal NH. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3. J Viral Hepat. 2013;20:669\u201377.","journal-title":"J Viral Hepat"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-017-0745-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-017-0745-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-017-0745-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T08:05:08Z","timestamp":1494230708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-017-0745-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s12664-017-0745-5","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}